Protection of Gingival Epithelium against Complement-mediated Damage by Strong Expression of the Membrane Attack Complex Inhibitor Protectin (CD59)

Abstract

Adult periodontitis (AP) is a chronic inflammatory disease of the tooth-supporting apparatus. Activation products of the inflammation-inducing complement system have been detected in the gingival crevicular fluid at the site of gingival inflammation. In the present study, we examined whether evidence for ongoing complement activation in gingival tissues of patients with AP can be obtained. In light of the potential tissue-damaging effects of the complement system, we also examined how the gingival tissue is protected against the cytolytic activity of complement. Surgical and autopsy samples of AP (n = 18) and healthy (n = 11) gingiva were analyzed for the expression or deposition of the complement regulators protectin (CD59) and vitronectin (S-protein) and complement components C3d and C9 by indirect immunofluorescence microscopy with specific antibodies. In healthy gingiva, protectin was strongly expressed on the membranes of epithelial cells and on the vascular endothelia of the underlying connective tissue. In AP, protectin was also strongly expressed by endothelial cells, but in the epithelia the expression was granular and weaker than in the healthy gingiva. Coarse granular deposits of complement components were seen in the subepithelial tissues of 61% (C3d), 39% (C9), and 33% (vitronectin) of AP patients, compared with 9% (one case in 11) in healthy controls. In addition, deposits of C3d, C9, and vitronectin were observed on the basement membranes of both pocket and oral epithelium of healthy and AP gingiva but not at sites of protectin expression. The results suggest an increased turnover of the complement system in the gingival tissues of AP patients. The gingival epithelium and connective tissue endothelia are well-protected against damage by the membrane attack complex of complement (MAC). Protection of the underlying connective tissue is insufficient, however, and may allow for deposition of MAC and autologous tissue damage in AP.

Keywords

periodontal disease complement CD59 complement inhibition periodontium

Get full access to this article

View all access options for this article.

References

Ainamo J. , Barmes D. , Beagrie G. , Cutress T. , Martin J. , Sardo-Infirri J. (1982). Development of the world health organization (WHO) community periodontal index of treatment needs (CPITN). Int Dent J 32:281-291.

Bhakdi S. , Kaflein R. , Halstensen TS , Hugo F. , Preissner KT , Mollnes TE (1988). Complement S-protein (vitronectin) is associated with cytolytic membrane bound C5b-9 complexes. Clin Exp Immunol 74:459-464.

Davies A. , Simmons DL , Hale G. , Harrison RA , Tighe H. , Lachmann PJ , et al. (1989). CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of

the complement membrane attack complex on homologous cells. J Exp Med 170:637-654.

Hamada S. , Holt SC , McGhee JR (1991). Periodontal disease pathogens & host immune responses. Tokyo: Quintessence Books .

Heimer GV , Taylor Ced (1974). Improved mountant for immunofluorescence preparations . J Clin Pathol 27:254-256. Leivo I. , Engvall E. (1986). C3d fragment of complement interacts with laminin and binds to basement membranes of glomerulus and trophoblast. J Cell Biol 103:1091-1100.

Meri S. , Morgan BP , Davies A. , Daniels RH , Olavesen MG , Waldmann H. , et al. (1990). Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 71:1-9.

Meri S. , Waldmann H. , Lachmann PJ (1991). Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues. Lab Invest 65:532-537. Meri S. , Mattila P. , Renkonen R. (1993). Regulation of CD59 expression on the human endothelial cell line EA.hy 926. Eur J Immunol 23:2511-2516.

Morgan BP , Meri S. ( 1994). Membrane proteins that protect against complement lysis . Springer Semin Immunopathol 15:369-396.

10.

Nakano Y. , Noda K. , Endo T. , Kobata A. , Tomita M. (1994). Structural study on the glycosyl-phosphatidylinositol anchor and the asparagine-linked sugar chain of a soluble form of CD59 in human urine. Arch Biochem Biophys 311:117-126.

11.

Niekrash CE , Patters MR (1985). Simultaneous assessment of complement components C3, C4, and B and their cleavage products in human gingival fluid. II. Longitudinal changes during periodontal therapy. J Periodont Res 20:268-275. Patters MR , Niekrash CE , Lang NP (1989). Assessment of complement cleavage in gingival fluid during exprimental gingivitis in man. J Clin Periodontal 16:33-37.

12.

Rollins SA , Sims PJ ( 1990). The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J Immunol 144:3478-3483.

13.

Rosse WF (1990). Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria. Blood 75:1595-1601. Rus HG , Niculescu F. , Vlaicu R. (1987). Presence of C5b-9 complement complex and S-protein in human myocardial areas with necrosis and sclerosis. Immunol Lett 16:15-20. Sargiacomo M. , Sudol M. , Tang ZL , Lisanti MP (1993). Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol 122:789-807.

14.

Savill J. , Dransfield I. , Hogg N. , Haslett C. (1990). Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 343:170-173.

15.

Schenkein HA , Genco RJ (1977). Gingival fluid and serum in periodontal diseases: II. Evidence for cleavage of complement componennts C3, C3 proactivator (factor B), and C4 in gingival fluid. J Periodontol 48:778-784. Schenkein HA , Cianciola L. , Genco RJ (1976). Complement activation in gingival pocket fluid from patients with periodontosis and severe periodontitis (abstract). J Dent Res 55(B):207.

16.

Sorsa T. , Suomalainen K. , Uitto V-J. (1990). The role of gingival crevicular fluid and salivary interstitial collagenases in human

17.

periodontal diseases. Arch Oral Biol 35(Suppl):193-196. Steffensen B. , Duong AH , Milam SB , Potempa CL , Winbom WB , Magnuson VL , et al. (1992). Immunohistochemical localization of cell adhesion proteins and integrins in the periodontium. J Periodontol 63:584-592.

18.

Sugita Y. , Ito K. , Shiozuka K. , Suzuki H. , Gushima H. , Tomita M. , et al. (1994). Recombinant soluble CD59 inhibits reactive haemolysis with complement. Immunology 82:34-41. Väkevä A. , Laurila P. , Meri S. ( 1992). Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction . Lab

19.

Invest 67:608-616.

20.

Vakeva A. , Laurila P. , Meri S. ( 1993). Regulation of complement membrane attack complex formation in myocardial infarction. Am J Pathol 143:65-75. Vakeva A. , Jauhiainen M. , Ehnholm C. , Lehto T. , Meri S. ( 1994). High-density lipoproteins can act as carriers of glycophosphoinositol lipid-anchored CD59 in human plasma. Immunology 82:28-33. Yancey KB , Basset-Seguin N. (1990). Studies of C3d,g in normal human epidermal basement membrane. J Invest Dermatol 94:122S-127S.